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Abstract
Background Acute stroke is a leading cause of morbidity
and mortality. Clinical trials in stroke are challenging
because victims often do not have the capacity to provide
informed consent, excluding those patients most likely to
benefit from the research.
Aim We evaluated patient willingness to participate in a
hypothetical acute stroke trial using an exception from
informed consent.
Methods Consecutive patients presenting to four emergency
departments (EDs) underwent structured interviews regarding
a hypothetical stroke trial using an exception from informed
consent.
Results Of 461 (72% of eligible) participants, 55% (95% CI,
50%–59%) were willing to be enrolled in the hypothetical
study without giving informed consent. After multivariable
analysis, independent predictors of willingness to enroll
included Catholic religion (OR 1.57, 95% CI 1.17–2.10) and
belief that current therapy offers a >50% chance of full
recovery (OR 1.29, 95% CI 1.05–1.57). There was no
difference between the proportion willing to enroll in a
cardiac arrest study vs. a stroke study (55% vs. 55%, p=0.83)
Conclusions Fifty-five percent of ED patients would be
willing to be enrolled in a stroke trial using exception from
informed consent.
Keywords Informed consent.Public opinion.Stroke
Introduction
Acutestrokeisaleadingcauseofmorbidityandmortality,and
few interventions have proven to improve outcome [1].
Altered mental status among stroke victims limits their
ability to give informed consent, which excludes those
patients most likely to benefit, skewing the study population
towards those with the least severe strokes [2–4]. Therefore,
some have advocated for use of an exception from the
standard informed consent procedure [5, 6]. While research
using this exception is allowable under federal regulations,
the process is both logistically and ethically complex, and
typically applied to a narrow range of diseases.
When stroke survivors and caregivers are involved in
stroke trial development, they have advocated for exception
from consent [7]. The only study examining patient opinion
of such an exception interviewed patients after their stroke
had occurred, finding that 92% would be willing to
participate [8]. These patients may be more aware of the
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DOI 10.1007/s12245-010-0244-2long-term morbidity of stroke and the limitations of current
therapies, and thus be more supportive of such research
than the general public.
To investigate public opinion, we interviewed a
consecutive cohort of patients presenting to the emer-
gency department (ED) for a variety of conditions [9].
Since it is impossible to discuss this issue with actual
patients at the time of their stroke, we interviewed patients
i nt h eE Dw h ow o u l db em o r ea w a r eo ft h en e e df o r
emergency evaluation and treatment, but be cognitively
intact. The primary analysis examined the effect of an
educational intervention on patient opinion of exception
from consent in general and was published previously [9].
Here, we report a secondary analysis examining indepen-
dent predictors of participants’ willingness to participate
in a stroke trial in particular.
Methods
We described the study design previously, including the
full questionnaire text [9]. Briefly, consecutive patients
presenting to four EDs during selected 24-h periods were
approached. Adults (aged >18) who were awake and
responsive were eligible for enrollment. Subjects were
excluded for medical instability, mental illness, intoxica-
tion, complaint of sexual assault, or if they were prisoners.
The original study tested the hypothesis that an educa-
tional intervention would increase willingness to partici-
pate; subjects were randomized to receive the control
survey or one with a paragraph discussing the ethical/legal
requirements involved in using exception from informed
consent [9]. The hypothetical stroke study is shown in
Fig. 1; subjects were also asked about a hypothetical
cardiac arrest study.
For analysis of the dichotomous variable “willing to
enroll,” we collapsed answers from a 5-point Likert scale
into “agree” (the responses Strongly Agree and Agree), and
“do not agree” (Neutral, Disagree, and Strongly Disagree).
We performed multivariable logistic regression to deter-
mine predictors of willingness to participate, with predictor
variables chosen a priori based upon previously published
data or suspected influence on willingness to participate in
research. The model included a term for site, to account for
within-ED clustering. We used Stata 9.0 (StataCorp,
College Station, TX) for analysis. We also collected
qualitative data using open-ended questions. The study
was approved by the Institutional Review Boards of all
participating sites.
Results
Of 1,080 patients presenting to the four EDs during the
study period, 640 were eligible, 473 participated, and
461 (72%) answered all questions including opinion on
the hypothetical stroke study (Table 1). Fifty-five
percent would be willing to participate in the hypothetical
stroke study, a similar proportion to that willing to
participate in a hypothetical cardiac arrest study (also
55%, p=0.83). Univariate analysis identified no signifi-
cant predictors of willingness to participate in the
hypothetical stroke study. Multivariate analysis identified
the following independent predictors of willingness to be
enrolled: male sex, Catholic religion, and belief that
current therapy offers >50% chance of full recovery
(Table 2).
Qualitative comments were provided by 37 (15%) of
those who were willing to participate, and by 50 (24%) who
were neutral or unwilling. The most common statement was
the belief that a surrogate is always immediately available
(n=15). Other common statements included that the risks
were too high (n=10); that the research should proceed in
case it might help (n=6); and that patients should only be
enrolled if it were already known that the treatment would
help (n=4).
Case Scenario: When a person has an acute stroke, they can suddenly lose control 
of their arms, legs, or ability to speak with or understand other people. There is a 
new treatment for this but it must be given immediately. Doctors think that this 
medication will increase the chance of recovering brain function in some patients, 
but are worried that it may increase the risk of bleeding in the brain. They need to 
do a study to find out if this treatment helps people; however, people with a stroke 
may not be able to give their consent for such a study. 
Question: If I had an acute stroke and could no longer understand or provide 
consent, I would be willing to be entered into this study without giving consent.
1. Strongly disagree   3. Neutral 4. Agree
2. Disagree 5. Strongly agree
Fig. 1 Case scenario
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We found that 55% of potential subjects would be willing
to participate in a stroke trial without informed consent,
11% were neutral, and 34% would refuse. Prior research
has shown 34–84% of respondents to be willing to
participate in other studies such as cardiac arrest without
informed consent [10].
Disagree Neutral Agree P value
Overall (n=461) 34% 11% 55%
Age, median (IQR) 46 (27–63) 43 (29–59) 47 (31–59) 0.95
Income in $1,000 s, median (IQR) 59 (47–79) 59 (47–68) 66 (47–79) 0.74
Sex 0.61
Male (n=214) 31% 9% 60%
Female (n=241) 36% 12% 51%
Race 0.69
White (n=290) 33% 11% 57%
Black (n=80) 38% 11% 51%
Other (n=77) 36% 14% 49%
Ethnicity 0.25
Non-Hispanic (n=400) 34% 11% 55%
Hispanic (n=18) 32% 12% 56%
Religion 0.30
Protestant (n=100) 36% 15% 49%
Catholic (n=192) 34% 7% 59%
Other (n=85) 28% 20% 52%
None (n=81) 37% 6% 57%
Strong connection to religion 0.52
No (n=230) 33% 10% 56%
Yes (n=148) 34% 14% 51%
Education 0.62
<8th grade (n=22) 23% 14% 64%
<12th grade (n=23) 30% 9% 61%
High school (n=132) 34% 12% 54%
Some college (n=109) 39% 7% 53%
College (n=113) 34% 13% 53%
Post grad. (n=62) 32% 11% 56%
Insurance 0.84
Private (n=262) 33% 11% 56%
Medicare (n=18) 17% 11% 72%
Medicaid (n=62) 35% 11% 53%
None (n=24) 33% 4% 63%
Other (n=88) 39% 11% 50%
“What do you think your chance of recovering … is, based on current therapies?”
<5% (n=27) 41% 4% 55%
5–50% (n=94) 38% 10% 52%
50/50 (n=176) 33% 14% 53%
>50% (n=120) 32% 12% 57%
>95% (n=30) 20% 7% 73% 0.30
Educational intervention 1.0
No (n=233) 34% 11% 55%
Yes (n=228) 35% 11% 54%
Table 1 Demographic
characteristics, by willingness
to participate in a hypothetical
stroke trial
*IQR, Interquartile range
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more optimistic view of the benefits of current therapies
were more willing to participate. It may be that those
with more positive opinions of clinical care also have
more faith in the ethical management of clinical trials or
a greater belief that research carries clinical benefit for
the participants. We also noted an effect of sex and
religious affiliation on willingness to enroll; the reason
for this is unclear. Future studies will be necessary to
clarify whether these relationships are artifacts of
multiple hypothesis testing, or whether there is a reason
that males and Catholics are more willing to participate
in research without consent.
Our study is limited by the fact that not all eligible
subjects completed the survey; a response rate over 80%
would be preferred. Also, by excluding the most severely ill
patients, we may have missed those most likely to be
enrolled in studies using an exception from informed
consent and whose opinions are most critical. Unfortunately,
while such patients who survive cognitively intact could be
interviewed after their clinical course has stabilized, such
interviews would select for those who benefited most from
standardtherapy,anddecision-makingatthetimeofthestroke
may be quite different from that made long afterwards.
Finally, healthy people at risk for stroke could be interviewed
toavoidanybiasesfrombeingintheemergencydepartmentat
thetimeofthesurvey.However,patients’opinionsofresearch
(andmedicalcare)maybequitedifferentwheninclosespatial
andpsychological proximity to a truemedical emergency,and
so such surveys may introduce a separate set of biases.
These data add to the growing body of evidence for
patients’ support of emergency research without informed
consent. Clinical trials in stroke have not traditionally been
considered candidates for exception from consent; however,
our data support the concept that within the context of
current federal regulations (including factors such as
clinical equipoise, ethics board approval, and absence of a
surrogate), the majority of patients would be willing to
participate in clinical trials of novel stroke therapies without
consent.
Clinical factor Odds ratio (95% CI)
Age per decade 1.0 (0.8–1.2)
Household income (per US$10,000) 1.0 (0.9–1.1)
Female sex 0.8 (0.7–0.9)
Race:
White Referent
Black 1.0 (0.7–1.6)
Other 0.7 (0.5–1.0)
Hispanic ethnicity 1.2 (0.5–2.7)
Education:
<8th grade Referent
Some high school 0.9 (0.4–2.0)
High school 0.8 (0.4–1.4)
Some college 0.8 (0.4–1.3)
College 0.8 (0.4–1.7)
Post graduate 1.1 (0.4–3.0)
Religion:
Protestant Referent
Catholic 1.6 (1.2–2.1)
Other 1.1 (0.6–2.0)
None 1.4 (0.7–2.8)
Insurance:
Private Referent
Medicare 2.1 (0.7–6.3)
Medicaid 0.9 (0.6–1.3)
None 1.3 (0.3–5.9)
Other 0.7 (0.2–2.7)
Belief that current therapies offer a >50% chance of full recovery 1.3 (1.1–1.6)
Educational intervention 1.0 (0.7–1.6)
Table 2 Multivariable
analysis of clinical features
associated with willingness to
participate in a hypothetical
stroke trial
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